Northern Trust Corp Milestone Pharmaceuticals Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 58,108 shares of MIST stock, worth $104,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,108
Previous 27,336
112.57%
Holding current value
$104,594
Previous $41,000
234.15%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
25.1MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$8.95 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$4.87 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.79 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.51 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$3.6 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $54M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...